Keystone Symposia SciTalk 2017: Toshihiro Horii

"Malaria vaccine development with SE36 recombinant protein"

Toshihiro Horii, Research Institute for Microbial Diseases, Osaka University

In February 2017, malaria experts from around the world gathered in Kampala, Uganda at "Malaria: From Innovation to Eradication(link is external)", a conference organized by Keystone Symposia(link is external) in collaboration with MESA.  SciTalks are in-conference short talks and poster presentations recorded on video and shared on the Internet, and are designed to extend the reach of the science present within each Keystone Symposia conference.  

Read more about Toshihiro's work:

Antibody titres and boosting after natural malaria infection in BK-SE36 vaccine responders during a follow-up study in Uganda

Yagi M, Palacpac NM, Ito K, Oishi Y, Itagaki S, Balikagala B, Ntege EH, Yeka A, Kanoi BN, Katuro O, Shirai H, Fukushima W, Hirota Y, Egwang TG, Horii T; Scientific Reports, 2016

Protective epitopes of the Plasmodium falciparum SERA5 malaria vaccine reside in intrinsically unstructured N-terminal repetitive sequences

Yagi M, Bang G, Tougan T, Palacpac NM, Arisue N, Aoshi T, Matsumoto Y, Ishii KJ, Egwang TG, Druilhe P, Horii T, PLoS One, 2014

Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36

Palacpac NMQ, Ntege E, Yeka A, Balikagala B, Suzuki N, et al; PLoS One, 2013

Evidences of protection against blood-stage infection of Plasmodium falciparum by the novel protein vaccine SE36

Horii T, Shirai H, Jie L, Ishii KJ, Palacpac NQ, Tougan T, Hato M, Ohta N, Bobogare A, Arakaki N, Matsumoto Y, Namazue J, Ishikawa T, Ueda S, Takahashi M; Parasitology International, 2010